Park Hyunjin, Cho Hyuna, Kim Heesuk, Lee Jihei Sara, Kim Chan Yun, Bae Hyoung Won
Department of Ophthalmology, Institute of Vision Research, Severance Eye Hospital, Yonsei University College of Medicine, Seoul, Korea.
Korean J Ophthalmol. 2025 Feb;39(1):1-13. doi: 10.3341/kjo.2024.0091. Epub 2024 Dec 23.
To compare the clinical outcomes of XEN45 gel stent implantation surgery (ab externo, open conjunctiva) with those of trabeculectomy.
We retrospectively reviewed electronic medical record of 57 patients (62 eyes) treated with XEN implantation surgery (ab externo, open conjunctival approach) between April 1, 2021, and July 31, 2023, by the same surgeon. Preoperative clinical data including intraocular pressure (IOP), the number of glaucoma medications, and visual acuity were collected from 1 day to 12 months postoperatively. These data were compared and analyzed with those of 67 patients (78 eyes) received trabeculectomy between February 1, 2017, and April 30, 2022, by the same surgeon. Statistical analyses were performed with p < 0.05 as significant.
Complete surgical success rate was 33.9% and 57.7% of the XEN and trabeculectomy groups, respectively (p = 0.005). The qualified success rate was 79.0% and 93.6%, respectively (p = 0.011). Postoperatively, the XEN group used more glaucoma medications than the trabeculectomy group (1.21 ± 1.05 vs. 0.69 ± 0.90, p = 0.003 at postoperative month 12). After postoperative month 1, the XEN group had a higher IOP (15.77 ± 5.07 mmHg vs. 13.17 ± 3.81 mmHg; at postoperative month 12, p = 0.001) and lower corneal astigmatism than the trabeculectomy group (1.32 ± 0.79 diopters vs. 1.88 ± 1.45 diopters, p = 0.020 at postoperative month 6). There was no significant difference in preoperative and postoperative best-corrected visual acuity (logMAR) between the groups at any of the follow-up period (favorable visual acuity subgroup; logMAR < 0.7). Postoperative complications were 0 cases of XEN group and 13 cases of trabeculectomy group (0% vs. 16.7%, p = 0.001). Also, XEN surgery (24 minutes 40 seconds ± 6 minutes 26 seconds) had a shorter operation time than the trabeculectomy (40 minutes 18 seconds ± 8 minutes 27 seconds, p < 0.001).
Compared to trabeculectomy, XEN surgery (ab externo, open conjunctiva) showed relatively lower effectiveness (surgical success rate, IOP reduction). However, it demonstrated advantages as a minimally invasive glaucoma surgery, including a surgical success rate approaching about 80%, stability in inducing corneal astigmatism, fewer postoperative complications, and shorter operation times.
比较XEN45凝胶支架植入手术(经外路,开放结膜)与小梁切除术的临床效果。
我们回顾性分析了同一位外科医生在2021年4月1日至2023年7月31日期间为57例患者(62只眼)实施XEN植入手术(经外路,开放结膜入路)的电子病历。收集术前临床数据,包括眼压(IOP)、青光眼用药数量和视力,术后1天至12个月的数据。将这些数据与同一位外科医生在2017年2月1日至2022年4月30日期间为67例患者(78只眼)实施小梁切除术的数据进行比较和分析。以p<0.05为有统计学意义进行统计分析。
XEN组和小梁切除术组的完全手术成功率分别为33.9%和57.7%(p = 0.005)。合格成功率分别为79.0%和93.6%(p = 0.011)。术后,XEN组使用的青光眼药物比小梁切除术组多(术后12个月时分别为1.21±1.05和0.69±0.90,p = 0.003)。术后1个月后,XEN组的眼压高于小梁切除术组(分别为15.77±5.07 mmHg和13.17±3.81 mmHg;术后12个月时,p = 0.001),角膜散光低于小梁切除术组(术后6个月时分别为1.32±0.79屈光度和1.88±1.45屈光度,p = 0.020)。在任何随访期,两组术前和术后最佳矫正视力(logMAR)均无显著差异(良好视力亚组;logMAR<0.7)。术后并发症方面,XEN组为0例,小梁切除术组为13例(0%对16.7%,p = 0.001)。此外,XEN手术(24分40秒±6分26秒)的手术时间比小梁切除术短(40分18秒±8分27秒,p<0.001)。
与小梁切除术相比,XEN手术(经外路,开放结膜)显示出相对较低的有效性(手术成功率、眼压降低)。然而,它作为一种微创青光眼手术具有优势,包括手术成功率接近80%,诱导角膜散光稳定,术后并发症少,手术时间短。